JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M009443200 on January 25, 2001

J. Biol. Chem., Vol. 276, Issue 16, 12805-12812, April 20, 2001
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
276/16/12805    most recent
M009443200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Goalstone, M. L.
Right arrow Articles by Draznin, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Goalstone, M. L.
Right arrow Articles by Draznin, B.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Insulin Signals to Prenyltransferases via the Shc Branch of Intracellular Signaling*

Marc L. GoalstoneDagger §, J. Wayne LeitnerDagger , Paulos Berhanu§, Prem M. Sharma||, Jerrold M. Olefsky||**Dagger Dagger , and Boris DrazninDagger §§§

From the Dagger  Veterans Affairs Medical Center Research Service and the § Department of Medicine, University of Colorado Health Sciences Center, Denver, Colorado 80220, the ** Veterans Affairs Medical Center Research Service, La Jolla, California 92161, and the || Department of Medicine, University of California at San Diego, and the Dagger Dagger  Whittier Diabetes Institute, La Jolla, California 92093

We assessed the roles of insulin receptor substrate-1 (IRS-1) and Shc in insulin action on farnesyltransferase (FTase) and geranylgeranyltransferase I (GGTase I) using Chinese hamster ovary (CHO) cells that overexpress wild-type human insulin receptors (CHO-hIR-WT) or mutant insulin receptors lacking the NPEY domain (CHO-Delta NPEY) or 3T3-L1 fibroblasts transfected with adenoviruses that express the PTB or SAIN domain of IRS-1 and Shc, the pleckstrin homology (PH) domain of IRS-1, or the Src homology 2 (SH2) domain of Shc. Insulin promoted phosphorylation of the alpha -subunit of FTase and GGTase I in CHO-hIR-WT cells, but was without effect in CHO-Delta NPEY cells. Insulin increased FTase and GGTase I activities and the amounts of prenylated Ras and RhoA proteins in CHO-hIR-WT (but not CHO-Delta NPEY) cells. Overexpression of the PTB or SAIN domain of IRS-1 (which blocked both IRS-1 and Shc signaling) prevented insulin-stimulated phosphorylation of the FTase and GGTase I alpha -subunit activation of FTase and GGTase I and subsequent increases in prenylated Ras and RhoA proteins. In contrast, overexpression of the IRS-1 PH domain, which impairs IRS-1 (but not Shc) signaling, did not alter insulin action on the prenyltransferases, but completely inhibited the insulin effect on the phosphorylation of IRS-1 and on the activation of phosphatidylinositol 3-kinase and Akt. Finally, overexpression of the Shc SH2 domain completely blocked the insulin effect on FTase and GGTase I activities without interfering with insulin signaling to MAPK. These data suggest that insulin signaling from its receptor to the prenyltransferases FTase and GGTase I is mediated by the Shc pathway, but not the IRS-1/phosphatidylinositol 3-kinase pathway. Shc-mediated insulin signaling to MAPK may be necessary (but not sufficient) for activation of prenyltransferase activity. An additional pathway involving the Shc SH2 domain may be necessary to mediate the insulin effect on FTase and GGTase I.


* This work was supported in part by the Medical Research Service of the Department of Veterans Affairs, National Institutes of Health Grant DK 54475 (to P. B.), the Foundation for Biomedical Education and Research, the Denver Research Institute, the HealthONE Foundation, the Diabetes and Endocrine Research Fund, and the American Diabetes Association.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Supported by a fellowship from the American Heart Association and recipient of a Veterans Affairs Research Service career development award.

§§ To whom correspondence should be addressed: VA Medical Center (151), 1055 Clermont St., Denver, CO 80220. Tel.: 303-393-4619; Fax: 303-377-5686; E-mail: Boris.Draznin@med.va.gov.


Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Integr Cancer TherHome page
M. F. McCarty and K. I. Block
Preadministration of High-Dose Salicylates, Suppressors of NF-{kappa}B Activation, May Increase the Chemosensitivity of Many Cancers: An Example of Proapoptotic Signal Modulation Therapy.
Integr Cancer Ther, September 1, 2006; 5(3): 252 - 268.
[Abstract] [PDF]


Home page
J. Lipid Res.Home page
K. F. Leung, R. Baron, and M. C. Seabra
Thematic review series: Lipid Posttranslational Modifications. Geranylgeranylation of Rab GTPases
J. Lipid Res., March 1, 2006; 47(3): 467 - 475.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Bernier, Y.-K. Kwon, S. K. Pandey, T.-N. Zhu, R.-J. Zhao, A. Maciuk, H.-J. He, R. DeCabo, and S. Kole
Binding of Manumycin A Inhibits I{kappa}B Kinase beta Activity
J. Biol. Chem., February 3, 2006; 281(5): 2551 - 2561.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
H. Ohkawara, T. Ishibashi, T. Sakamoto, K. Sugimoto, K. Nagata, K. Yokoyama, N. Sakamoto, M. Kamioka, I. Matsuoka, S. Fukuhara, et al.
Thrombin-induced Rapid Geranylgeranylation of RhoA as an Essential Process for RhoA Activation in Endothelial Cells
J. Biol. Chem., March 18, 2005; 280(11): 10182 - 10188.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
C. C. L. Wang, M. L. Goalstone, and B. Draznin
Molecular Mechanisms of Insulin Resistance That Impact Cardiovascular Biology
Diabetes, November 1, 2004; 53(11): 2735 - 2740.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. W. Siddals, E. Marshman, M. Westwood, and J. M. Gibson
Abrogation of Insulin-like Growth Factor-I (IGF-I) and Insulin Action by Mevalonic Acid Depletion: SYNERGY BETWEEN PROTEIN PRENYLATION AND RECEPTOR GLYCOSYLATION PATHWAYS
J. Biol. Chem., September 10, 2004; 279(37): 38353 - 38359.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
T. Kondo and C. R. Kahn
Altered Insulin Signaling in Retinal Tissue in Diabetic States
J. Biol. Chem., September 3, 2004; 279(36): 37997 - 38006.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
E. Audero, I. Cascone, F. Maniero, L. Napione, M. Arese, L. Lanfrancone, and F. Bussolino
Adaptor ShcA Protein Binds Tyrosine Kinase Tie2 Receptor and Regulates Migration and Sprouting but Not Survival of Endothelial Cells
J. Biol. Chem., March 26, 2004; 279(13): 13224 - 13233.
[Abstract] [Full Text] [PDF]


Home page
MicrobiologyHome page
J. L. Song and T. C. White
RAM2: an essential gene in the prenylation pathway of Candida albicans
Microbiology, January 1, 2003; 149(1): 249 - 259.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
J. Farhang-Fallah, V. K. Randhawa, A. Nimnual, A. Klip, D. Bar-Sagi, and M. Rozakis-Adcock
The Pleckstrin Homology (PH) Domain-Interacting Protein Couples the Insulin Receptor Substrate 1 PH Domain to Insulin Signaling Pathways Leading to Mitogenesis and GLUT4 Translocation
Mol. Cell. Biol., October 15, 2002; 22(20): 7325 - 7336.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
D. J. Klemm, J. W. Leitner, P. Watson, A. Nesterova, J. E.-B. Reusch, M. L. Goalstone, and B. Draznin
Insulin-induced Adipocyte Differentiation. ACTIVATION OF CREB RESCUES ADIPOGENESIS FROM THE ARREST CAUSED BY INHIBITION OF PRENYLATION
J. Biol. Chem., July 20, 2001; 276(30): 28430 - 28435.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Montagnani, I. Golovchenko, I. Kim, G. Y. Koh, M. L. Goalstone, A. N. Mundhekar, M. Johansen, D. F. Kucik, M. J. Quon, and B. Draznin
Inhibition of Phosphatidylinositol 3-Kinase Enhances Mitogenic Actions of Insulin in Endothelial Cells
J. Biol. Chem., January 11, 2002; 277(3): 1794 - 1799.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
J. Chappell, J. W. Leitner, S. Solomon, I. Golovchenko, M. L. Goalstone, and B. Draznin
Effect of Insulin on Cell Cycle Progression in MCF-7 Breast Cancer Cells. DIRECT AND POTENTIATING INFLUENCE
J. Biol. Chem., October 5, 2001; 276(41): 38023 - 38028.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. R. Jacobs, D. LeRoith, and S. I. Taylor
Insulin Receptor Substrate-1 Pleckstrin Homology and Phosphotyrosine-binding Domains Are Both Involved in Plasma Membrane Targeting
J. Biol. Chem., October 26, 2001; 276(44): 40795 - 40802.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.